Cytokeratin 6A Inhibitors
Cytokeratin 6A inhibitors are a class of chemical compounds that specifically target and inhibit the function of Cytokeratin 6A, a type of intermediate filament protein primarily expressed in epithelial tissues. Cytokeratin 6A belongs to the larger family of cytokeratins, which are integral to the structural integrity and mechanical support of cells. These proteins form a network of filaments that contribute to the cytoskeleton, helping to maintain cell shape, resist mechanical stress, and facilitate intracellular transport. Inhibiting Cytokeratin 6A disrupts its ability to polymerize into filaments, impacting the overall stability and organization of the cytoskeletal network within epithelial cells.
The mechanisms by which Cytokeratin 6A inhibitors work can vary. Some inhibitors may interfere with the protein's ability to form filamentous structures by directly binding to its monomeric form, preventing its assembly into the intermediate filament network. Others may alter the protein's interaction with associated molecules, affecting its role in cellular adhesion, migration, and differentiation. By blocking the activity of Cytokeratin 6A, these inhibitors provide researchers with valuable tools for studying the role of cytokeratins in maintaining the mechanical resilience of epithelial tissues, as well as their involvement in processes like wound healing and epithelial cell turnover. The inhibition of Cytokeratin 6A allows for a deeper exploration of its contributions to cellular architecture, helping to elucidate how structural proteins like cytokeratins regulate various aspects of epithelial cell behavior and organization.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil is an antimetabolite that can indirectly affect Cytokeratin 6A by disrupting DNA synthesis, impacting cell proliferation where Cytokeratin 6A is overexpressed, such as in certain cancers. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin, a chemotherapy agent, can indirectly influence Cytokeratin 6A expression in cancer cells by causing DNA damage and affecting cell cycle progression. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel is a microtubule stabilizer and can indirectly affect Cytokeratin 6A by disrupting cell division, potentially impacting its expression in rapidly dividing cells. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, a proteasome inhibitor, might indirectly impact Cytokeratin 6A levels by altering protein degradation pathways, which could affect the turnover of structural proteins like keratins. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate, an antimetabolite and antifolate drug, can influence Cytokeratin 6A indirectly by inhibiting DNA synthesis and cell proliferation, particularly in hyperproliferative conditions. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, known for its anti-inflammatory and antioxidant properties, could indirectly modulate Cytokeratin 6A expression by altering signaling pathways involved in cell stress and proliferation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, a metabolite of Vitamin A, can influence the differentiation of epithelial cells and potentially modulate Cytokeratin 6A expression as part of the differentiation process. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a major component of green tea, has antioxidant properties and could indirectly affect Cytokeratin 6A expression by modulating cell signaling pathways involved in stress and inflammation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, could indirectly influence Cytokeratin 6A by altering cell growth and protein synthesis pathways, which are crucial in conditions where keratin expression is dysregulated. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib, a kinase inhibitor, might indirectly impact Cytokeratin 6A expression through its effects on cell signaling pathways, particularly in cancer cells. | ||||||